L, S., Y, W., S, Z., Y, L., Z, L., Y, Z., . . . Y, S. (2025). ROS-Responsive Nanosystem Targeted Co-Delivery YC-1 and Regorafenib to Alleviate Hypoxia Enhancing Hepatocellular Carcinoma Therapy. Dove Medical Press.
Chicago Style (17th ed.) CitationL, Song, et al. ROS-Responsive Nanosystem Targeted Co-Delivery YC-1 and Regorafenib to Alleviate Hypoxia Enhancing Hepatocellular Carcinoma Therapy. Dove Medical Press, 2025.
MLA (9th ed.) CitationL, Song, et al. ROS-Responsive Nanosystem Targeted Co-Delivery YC-1 and Regorafenib to Alleviate Hypoxia Enhancing Hepatocellular Carcinoma Therapy. Dove Medical Press, 2025.
Warning: These citations may not always be 100% accurate.